Skip to main content

Closed

SNGX: Soligenix, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-327.0%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage0.0×

Current ratio1.81×

Soligenix, Inc.

SNGXNASDAQ Capital Market·USD·Closed

Soligenix, Inc.

SNGXNASDAQ·USD·Closed

$0.37

−0.29%

$0.37

−$0.00 (0.29%)

52W Range

2thpctl

Volume

0.04×avg

Mkt Cap

5.54MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.04×avg

Market Cap

5.54MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings